Medication info
Tizgip Simetidine Tablet

Tizgip Simetidine Tablet

Prescription medicationTabletOral
Ingredient · strength
Cimetidine›200mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
Light green round tablet
Packaging
1000 tablets/bottle
Approval status
Active

MFDS item code 201307639 · Approved 2013.06.10 · Insurance code 640904750

Summary

Main use
Treatment of acid-related disorders (such as gastric ulcers and reflux esophagitis) and improvement of gastric mucosal lesions associated with gastritis
Who takes it
Adults · Children
Adult dose
1. Adults: Administer 400 mg of cimetidine orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) associated with acute gastritis or acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. 3. Antacids may be administered as needed for pain relief. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. 4. Patients with renal impairment: Administer 300 mg of this medication twice daily, every 12 hours. Depending on the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more, if necessary, but use caution. Since the medication may accumulate in the body in patients with severe renal impairment, reduce the frequency of administration to a minimum according to the patient's response. Hemodialysis lowers blood cimetidine levels. After hemodialysis is completed, administer the medication again according to the schedule. Adjust the dose as appropriate according to age and symptoms.
Child dose
Administer 20 ~ 40 mg per kg of body weight per day orally in divided doses.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as gastric ulcers and reflux esophagitis) and improvement of gastric mucosal lesions associated with gastritis

  • Gastric ulcer
  • duodenal ulcer
  • gastroesophageal reflux disease
  • recurrent ulcer
  • anastomotic ulcer
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is used in the treatment of ulcers occurring in the stomach and duodenum, gastroesophageal reflux disease, recurrent ulcers, anastomotic ulcers, and Zollinger-Ellison syndrome. It also improves symptoms such as erosion, bleeding, redness, and swelling of the gastric mucosa that appear during acute exacerbations of acute and chronic gastritis. This medication helps to promote the health of the gastric mucosa and alleviate uncomfortable symptoms.

How to take

Adult dose

1. Adults: Administer 400 mg of cimetidine orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) associated with acute gastritis or acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. 3. Antacids may be administered as needed for pain relief. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. 4. Patients with renal impairment: Administer 300 mg of this medication twice daily, every 12 hours. Depending on the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more, if necessary, but use caution. Since the medication may accumulate in the body in patients with severe renal impairment, reduce the frequency of administration to a minimum according to the patient's response. Hemodialysis lowers blood cimetidine levels. After hemodialysis is completed, administer the medication again according to the schedule. Adjust the dose as appropriate according to age and symptoms.

Child dose

Administer 20 ~ 40 mg per kg of body weight per day orally in divided doses.

Precautions

This medication contains the ingredient cimetidine and should not be administered to certain patients. For example, patients who are allergic to cimetidine or have experienced hypersensitivity reactions to this medication or its other ingredients should not use it. Furthermore, patients who are taking a drug called dofetilide may have an increased risk of cardiac arrhythmias, so this medication should not be administered. This medication contains lactose and should not be used by patients with lactose intolerance or certain genetic metabolic disorders. Caution is needed when using this medication in patients with renal or hepatic impairment, those with a history of drug allergies, elderly patients, children under 19 years of age, and patients undergoing hemodialysis. This medication may mask symptoms of gastric cancer, so it should be administered only after confirming malignancy, and patients with Helicobacter pylori infection should receive eradication therapy concurrently. Additionally, patients allergic to the dye Yellow No. 4 (tartrazine) included in this medication should exercise caution. While taking this medication, rare side effects such as decreased blood cell counts, liver dysfunction, renal problems, hypersensitivity reactions, hormonal imbalance, gastrointestinal symptoms, neurological symptoms, cardiac arrhythmias, and skin reactions may occur, so patients should consult a physician immediately if symptoms arise. It is especially important to undergo regular blood tests and liver and kidney function tests to monitor the condition, and if symptoms are severe, the medication should be discontinued, and appropriate treatment obtained. This medication has many drug interactions; therefore, dose adjustment or drug holidays may be necessary when taken with anticoagulants like warfarin, antidepressants, antiarrhythmics, calcium channel blockers, diabetes medications, and antifungals. Women who are pregnant or breastfeeding should consider the necessity and risks of using this medication, as its safety has not been fully established. It is best to avoid breastfeeding while taking this medication. The safety of this medication in children has not been sufficiently proven, and it should only be used when absolutely necessary, while elderly patients should adjust the dose and intervals due to possible renal function decline. In cases of overdose, severe symptoms such as respiratory depression may occur, requiring immediate emergency treatment at a hospital. Finally, this medication should be kept out of reach of children, and care should be taken not to transfer it to other containers, as this may adversely affect the quality and safety of the medication.

Side effects

  • Leukopenia
  • neutropenia
  • agranulocytosis
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • immune hemolytic anemia
  • jaundice
  • hepatitis
  • elevated AST
Show 48 more
  • elevated ALT
  • abnormal liver function
  • hepatic fibrosis
  • interstitial seizures
  • acute renal failure
  • interstitial nephritis
  • urinary retention
  • elevated BUN
  • shock
  • anaphylaxis-like reaction
  • hypersensitivity vasculitis
  • rash
  • gynecomastia
  • hypersecretion of prolactin
  • increased leukorrhea
  • erectile dysfunction
  • abdominal bloating
  • constipation
  • diarrhea
  • headache
  • dizziness
  • convulsions
  • limb numbness
  • stiffness
  • drowsiness
  • hypochondriacal symptoms
  • weakness
  • altered consciousness
  • delirium
  • bradycardia
  • tachycardia
  • palpitations
  • heart block
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • epidermal necrosis
  • erythema multiforme
  • exudative dermatitis
  • generalized exudative erythema
  • fatigue
  • fever
  • systemic heat sensation
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • hair loss
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is advisable to maintain storage temperatures between 1°C and 30°C at room temperature. This helps to preserve the medication's effectiveness and safety for a long time.

Appearance and packaging

Appearance

Light green round tablet

Package unit

1000 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.